SE0102809D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0102809D0
SE0102809D0 SE0102809A SE0102809A SE0102809D0 SE 0102809 D0 SE0102809 D0 SE 0102809D0 SE 0102809 A SE0102809 A SE 0102809A SE 0102809 A SE0102809 A SE 0102809A SE 0102809 D0 SE0102809 D0 SE 0102809D0
Authority
SE
Sweden
Prior art keywords
novel compounds
methyl
compound
benzisoxazol
butanone
Prior art date
Application number
SE0102809A
Other languages
English (en)
Swedish (sv)
Inventor
Joergen Gustafsson
Nazifal Hossain
Stinabritt Nilsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102809A priority Critical patent/SE0102809D0/xx
Publication of SE0102809D0 publication Critical patent/SE0102809D0/xx
Priority to US10/486,504 priority patent/US20040209879A1/en
Priority to ES02760961T priority patent/ES2316601T3/es
Priority to DE60230047T priority patent/DE60230047D1/de
Priority to PCT/SE2002/001488 priority patent/WO2003018566A1/fr
Priority to JP2003523229A priority patent/JP2005501866A/ja
Priority to EP02760961A priority patent/EP1421070B1/fr
Priority to AT02760961T priority patent/ATE415393T1/de
Priority to EP08165498A priority patent/EP2020409A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0102809A 2001-08-22 2001-08-22 Novel compounds SE0102809D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0102809A SE0102809D0 (sv) 2001-08-22 2001-08-22 Novel compounds
US10/486,504 US20040209879A1 (en) 2001-08-22 2002-08-21 Piperidinyl derivates as modulators of chemokine receptor activity
ES02760961T ES2316601T3 (es) 2001-08-22 2002-08-21 Nuevos derivados de piperidinilo como moduladores de la actividad del receptor de quimiocina.
DE60230047T DE60230047D1 (de) 2001-08-22 2002-08-21 Neue piperidinylderivate als modulatoren der aktivität des chemokinrezeptors
PCT/SE2002/001488 WO2003018566A1 (fr) 2001-08-22 2002-08-21 Nouveaux derives de piperidinyle, utilises en tant que modulateurs de l'activite d'un recepteur de chimiokine
JP2003523229A JP2005501866A (ja) 2001-08-22 2002-08-21 ケモカイン受容体活性のモジュレーターとしての新規ピペリジニル誘導体
EP02760961A EP1421070B1 (fr) 2001-08-22 2002-08-21 Nouveaux derives de piperidinyle, utilises en tant que modulateurs de l'activite d'un recepteur de chimiokine
AT02760961T ATE415393T1 (de) 2001-08-22 2002-08-21 Neue piperidinylderivate als modulatoren der aktivität des chemokinrezeptors
EP08165498A EP2020409A1 (fr) 2001-08-22 2002-08-21 Nouveaux dérivés de piperidinyle, utilises en tant que modulateurs de l'activité d'un récepteur de chimiokine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102809A SE0102809D0 (sv) 2001-08-22 2001-08-22 Novel compounds

Publications (1)

Publication Number Publication Date
SE0102809D0 true SE0102809D0 (sv) 2001-08-22

Family

ID=20285106

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102809A SE0102809D0 (sv) 2001-08-22 2001-08-22 Novel compounds

Country Status (8)

Country Link
US (1) US20040209879A1 (fr)
EP (2) EP1421070B1 (fr)
JP (1) JP2005501866A (fr)
AT (1) ATE415393T1 (fr)
DE (1) DE60230047D1 (fr)
ES (1) ES2316601T3 (fr)
SE (1) SE0102809D0 (fr)
WO (1) WO2003018566A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
GB0117899D0 (en) 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
WO2005023771A1 (fr) * 2003-09-05 2005-03-17 Ono Pharmaceutical Co., Ltd. Antagoniste du recepteur de la chimiokine et son utilisation a des fins medicales
WO2007136790A2 (fr) 2006-05-18 2007-11-29 Mannkind Corporation Inhibiteurs de kinases intracellulaires
CN118831074B (zh) * 2024-07-01 2025-03-14 山东省科学院生物研究所 邻乙酰氨基酚在制备降血脂相关产品中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
EP0174654A3 (fr) * 1984-09-14 1987-07-22 Ciba-Geigy Ag Dérivés carbonyles
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
ES2230899T3 (es) * 1998-11-17 2005-05-01 F. Hoffmann-La Roche Ag Antagonistas iii receptores de 4-aroil-piperidin-ccr-3.
BR0009338A (pt) * 1999-03-26 2001-12-26 Astrazeneca Ab Composto, processo para a preparação do mesmo,composição farmacêutica, processo para apreparação da mesma, uso de um composto, e,método de tratamento de uma doençainflamatória em um paciente sofrendo ou em riscode dita doença
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
EP1318988A2 (fr) * 2000-09-11 2003-06-18 Sepracor, Inc. Ligands pour les recepteurs de monoamine et transporteurs, et procedes d'utilisation de ces derniers (neurotransmission)
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
ES2316601T3 (es) 2009-04-16
US20040209879A1 (en) 2004-10-21
EP1421070B1 (fr) 2008-11-26
WO2003018566A1 (fr) 2003-03-06
JP2005501866A (ja) 2005-01-20
EP1421070A1 (fr) 2004-05-26
DE60230047D1 (de) 2009-01-08
EP2020409A1 (fr) 2009-02-04
ATE415393T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
HUP0402338A3 (en) Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
CA2424664A1 (fr) Nouveaux composes non imidazole
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
ZA200700765B (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
MXPA03006357A (es) Composicion farmaceutica que tiene tendencia reducida a cristalizacion de farmaco.
MY131890A (en) Piperidine compounds
IS6994A (is) Arípíprazóllausn til gjafar um munn
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
SE9903544D0 (sv) Novel compounds
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
SI1417206T1 (sl) Novi H piridazin onski derivati farmacevtski sestavki ki jih vsebujejo in postopek za pripravo aktivne sestavine
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
GB0109122D0 (en) Novel compounds
MXPA04001968A (es) Agentes antidiabeticos.
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
SE0102809D0 (sv) Novel compounds